 |
 |
[3] MANNUCCI P,PEYVANDI F. TTP and ADAMTS13:When Is Testing Appropriate [J]?Hematology，2007， 121126
[4] ANIL K. C, DAVID G. M,COLIN B. L。Wolfgang Bergmeier,Michael Dockal. Systemic antithrombotic effects of ADAMTS13 [J].JEM，2006，203:767776。
[5] SHENKMAN B.The role of ADAMT13 in platelet adhesion in flow: methods for diagnosis of thrombotic thrombocytopenic purpura[J]. Pathophysiol Haemost Thromb，2006，35(12):98102.
[6] KOBAYASHI T,WADA H,KAMIKURA Y, et al。Decreased ADAMTS13 activity in plasma from patients with thrombotic thrombocytopenic purpura[J]. Thromb Res，2007，19(4):447452.
[7] BANNO F,KOKAME K.ADAMTS13 is a metalloprotease that regulates platelet aggregation in hemostasis[J]. Seikagaku，2006，78(6):528532.
[8] ARDALAN M R. Review of thrombotic microangiopathy (TMA), and postrenal transplant TMA[J]. Saudi J Kidney Dis Transpl， 2006 ，17(2):235244.
[9] ZIMMERHACKL LB,SCHEIRING J,Prufer F.Renal transplantation in HUS patients with disorders of complement regulation[J]. Pediatr Nephrol，2007 ，22(1):1016.
[10] SADLER J E.Thrombotic thrombocytopenic purpura: a moving target[J].Hematology Am Soc Hematol Educ Program，2006，41520.
[11] PLAIMAUER B, FUHRMANN J, MOHR G, et al. Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation[J].Blood，2006，107:118125。
[12] ONO T, MIMURO J, MADOIWA S, et al. Severe secondary deficiency of von Willebrand factor–cleaving protease (ADAMTS13) in patients with sepsisinduced disseminated intravascular coagulation: its correlation with development of renal failure[J].Blood，2006，107:528534。
[13] MATSUKAWA M ,KAIKITA K, SOEJIMA K, F et al. Serial change in von Willebrand Factorcleaving Protease (ADAMTS13)and Prognosis After Acute Myocardial Infraction[J].Am J Cardiol， 2007，100:758763。
[14] CHION CK,DOGGEN CJ,CRAWLEY JT,et al.ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men[J]. Blood， 2007 ，109(5):19982000.
[15] MANNUCCI P,VANOLI M,FORZA L, et al。 von Willebrand Factorcleaving Protease (ADAMTS13)in 123 patients with connective tissue diseases(systemic lupus erythematosus and systemic sclerosis) [J].Haematologica， 2003，88:914918。
[16] AUSTIN SK,STARKE RD,LAWRIE AS et al.The vWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibody and ADAMTS13dysfunction[J].Br J Haematol，2008 141(4):536544。
[17] MANNUCCI P,KARIMI M,MOSALAEI A, et al。, Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS13(von Willebrand Factorcleaving Protease) [J].Hemostasis ，2003，88:454458。
[18] NGUYEN TC,LIU A,LIU L, et al。.Acquired ADAMTS13 deficiency in pediatric patients with severe sepsis[J]. Haematologica， 2007， 92:121124。
[19] BONGERS TN, MAAT MP, GOOR ML, et al。.High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability[J]. Stroke， 2006 ，37(11):26722677.
